Xcout Intel
Tessera Therapeutics
Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Subscribe to see Tessera Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tessera Therapeutics at a glance
Tessera Therapeutics is a biotech company headquartered in United States. Xcout tracks 17 named people at Tessera Therapeutics, including Joseph Romanelli (President and Chief Executive Officer, Board Director). Xcout recorded 6 job postings from Tessera Therapeutics in the last 90 days.
Tessera Therapeutics leadership
- Joseph RomanelliPresident and Chief Executive Officer, Board Director
- Hari PujarChief Operating Officer
- Kathy BergsteinssonChief Financial Officer
- Becky LillieChief Human Resources Officer
- David DavidsonChief Medical and Development Officer
- Michael HolmesChief Scientific Officer
11 more named people on record for Tessera Therapeutics, with roles, board committees and tenure — see the full roster →
Hiring at Tessera Therapeutics
Xcout recorded 6 job postings from Tessera Therapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Tessera Therapeutics's hiring signals →
Tessera Therapeutics competitors
A few of Tessera Therapeutics's closest competitors — see the full list of competitors and alternatives →
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Azalea Therapeutics is a biotechnology company headquartered in Berkeley, California. The company focuses on precision genome engineering directly inside the body with an initial emphasis on developing in vivo cancer immunotherapies.
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
ArsenalBio is a biotechnology company developing programmable cell therapies, particularly engineered T-cell therapies, for cancer treatment. It serves biopharmaceutical and healthcare markets by using synthetic biology and genomic engineering to create more effective, controllable immune-cell medicines.
Get Tessera Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Tessera Therapeutics? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tessera Therapeutics in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access